{
  "experiment_id": "c76b8a3745d0bc475b41440188187f7d",
  "task_name": "translation_of_exact_synonyms",
  "task_hash": "8ad16d30616e7d6242f8204a96cf0019",
  "model_id": "us.amazon.nova-premier-v1:0",
  "system_instructions": "### Temperature\n\n1.0",
  "temperature": 1.0,
  "thinking": false,
  "tools": [],
  "timestamp": "2025-12-11T05:47:27.265147",
  "task_result": {
    "task_name": "translation_of_exact_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "NF1",
          "assay": "WEX",
          "tumorType": "pNF"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\nIn the provided input data, the synonyms were translated into their standard, preferred equivalents based on the Target Schema. Here are the steps and explanations:\n\n1. **Diagnosis Field:**\n   - Input: `\"NF1\"`\n   - The Target Schema's preferred term for \"NF1\" is `\"Neurofibromatosis type 1\"`.\n\n2. **Assay Field:**\n   - Input: `\"WEX\"`\n   - \"WEX\" is commonly understood as \"whole exome sequencing\".\n   - The Target Schema's preferred term for \"whole exome sequencing\" is `\"whole exome sequencing\"`.\n\n3. **Tumor Type Field:**\n   - Input: `\"pNF\"`\n   - \"pNF\" is a known abbreviation for \"Plexiform Neurofibroma\".\n   - The Target Schema's preferred term for this tumor type is `\"Plexiform Neurofibroma\"`.\n\nThese translations ensure that the metadata conforms exactly to the controlled terminology specified in the schema.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2629,
            "outputTokens": 277,
            "totalTokens": 2906
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "59379e76-f7d7-43a7-a5ec-fe81d71e0b09",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:46:59 GMT",
                "content-type": "application/json",
                "content-length": "1220",
                "connection": "keep-alive",
                "x-amzn-requestid": "59379e76-f7d7-43a7-a5ec-fe81d71e0b09"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\nIn the provided input data, the synonyms were translated into their standard, preferred equivalents based on the Target Schema. Here are the steps and explanations:\n\n1. **Diagnosis Field:**\n   - Input: `\"NF1\"`\n   - The Target Schema's preferred term for \"NF1\" is `\"Neurofibromatosis type 1\"`.\n\n2. **Assay Field:**\n   - Input: `\"WEX\"`\n   - \"WEX\" is commonly understood as \"whole exome sequencing\".\n   - The Target Schema's preferred term for \"whole exome sequencing\" is `\"whole exome sequencing\"`.\n\n3. **Tumor Type Field:**\n   - Input: `\"pNF\"`\n   - \"pNF\" is a known abbreviation for \"Plexiform Neurofibroma\".\n   - The Target Schema's preferred term for this tumor type is `\"Plexiform Neurofibroma\"`.\n\nThese translations ensure that the metadata conforms exactly to the controlled terminology specified in the schema."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2629,
              "outputTokens": 277,
              "totalTokens": 2906
            },
            "metrics": {
              "latencyMs": 3644
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2629,
          "output_tokens": 277,
          "total_tokens": 2906
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "neurofibromatosis type 1",
          "assay": "WES",
          "tumorType": "MPNST"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\nExplanation:\n1. **Diagnosis**: \"neurofibromatosis type 1\" is corrected to \"Neurofibromatosis type 1\" to match the exact casing and format as per the Target Schema.\n2. **Assay**: \"WES\" is expanded to \"whole exome sequencing\", which is the full form found in the Target Schema.\n3. **Tumor Type**: \"MPNST\" is expanded to \"Malignant Peripheral Nerve Sheath Tumor\", aligning with the controlled terminology in the schema. \n\nThis ensures all fields adhere strictly to the specified schema values without introducing any synonyms or variations.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2634,
            "outputTokens": 185,
            "totalTokens": 2819
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "bdd2e70d-fb0e-416a-85f9-26f3c98a9682",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:47:02 GMT",
                "content-type": "application/json",
                "content-length": "936",
                "connection": "keep-alive",
                "x-amzn-requestid": "bdd2e70d-fb0e-416a-85f9-26f3c98a9682"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\nExplanation:\n1. **Diagnosis**: \"neurofibromatosis type 1\" is corrected to \"Neurofibromatosis type 1\" to match the exact casing and format as per the Target Schema.\n2. **Assay**: \"WES\" is expanded to \"whole exome sequencing\", which is the full form found in the Target Schema.\n3. **Tumor Type**: \"MPNST\" is expanded to \"Malignant Peripheral Nerve Sheath Tumor\", aligning with the controlled terminology in the schema. \n\nThis ensures all fields adhere strictly to the specified schema values without introducing any synonyms or variations."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2634,
              "outputTokens": 185,
              "totalTokens": 2819
            },
            "metrics": {
              "latencyMs": 2957
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2634,
          "output_tokens": 185,
          "total_tokens": 2819
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "ORPHA:636",
          "assay": "WGS",
          "tumorType": "MPN tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation:**\n1. **Diagnosis:** The input \"ORPHA:636\" does not directly match any value in the `diagnosis` enum. Since there is no synonym or direct translation provided for this value, the closest match based on the context of unknown or unspecified conditions is \"Unknown\".\n2. **Assay:** \"WGS\" is commonly understood as \"Whole Genome Sequencing\", which translates to \"whole genome sequencing\" in the provided schema.\n3. **Tumor Type:** \"MPN tumor\" refers to a \"Malignant Peripheral Nerve Sheath Tumor\" based on the context provided in the enum values. This is the preferred terminology in the schema.\n\nBy adhering to the target schema, the translated values are exact matches from the provided enum lists.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2633,
            "outputTokens": 206,
            "totalTokens": 2839
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "1b23bdb6-1f50-474b-88da-c04326b2e2f0",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:47:06 GMT",
                "content-type": "application/json",
                "content-length": "1095",
                "connection": "keep-alive",
                "x-amzn-requestid": "1b23bdb6-1f50-474b-88da-c04326b2e2f0"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation:**\n1. **Diagnosis:** The input \"ORPHA:636\" does not directly match any value in the `diagnosis` enum. Since there is no synonym or direct translation provided for this value, the closest match based on the context of unknown or unspecified conditions is \"Unknown\".\n2. **Assay:** \"WGS\" is commonly understood as \"Whole Genome Sequencing\", which translates to \"whole genome sequencing\" in the provided schema.\n3. **Tumor Type:** \"MPN tumor\" refers to a \"Malignant Peripheral Nerve Sheath Tumor\" based on the context provided in the enum values. This is the preferred terminology in the schema.\n\nBy adhering to the target schema, the translated values are exact matches from the provided enum lists."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2633,
              "outputTokens": 206,
              "totalTokens": 2839
            },
            "metrics": {
              "latencyMs": 3875
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2633,
          "output_tokens": 206,
          "total_tokens": 2839
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "Von Recklinghausen's neurofibromatosis",
          "assay": "MRS",
          "tumorType": "NOS"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"magnetic resonance spectroscopy\",\n  \"tumorType\": \"Not Applicable\"\n}\n```\n\n### Explanation:\n1. **Diagnosis**:\n   - Original: \"Von Recklinghausen's neurofibromatosis\"\n   - The standard, preferred equivalent from the controlled terminology is: \"Neurofibromatosis type 1\"\n\n2. **Assay**:\n   - Original: \"MRS\"\n   - Assuming \"MRS\" refers to \"magnetic resonance spectroscopy\" based on common terminology in scientific contexts.\n   - The standard, preferred equivalent from the controlled terminology is: \"magnetic resonance spectroscopy\"\n\n3. **Tumor Type**:\n   - Original: \"NOS\"\n   - Assuming \"NOS\" refers to \"Not Otherwise Specified,\" but since the controlled terminology does not have this term, it's best matched with \"Not Applicable.\"\n   - The standard, preferred equivalent from the controlled terminology is: \"Not Applicable\"",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2636,
            "outputTokens": 232,
            "totalTokens": 2868
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "5be2aba6-3982-464f-96cb-14e82afa1161",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:47:09 GMT",
                "content-type": "application/json",
                "content-length": "1150",
                "connection": "keep-alive",
                "x-amzn-requestid": "5be2aba6-3982-464f-96cb-14e82afa1161"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"magnetic resonance spectroscopy\",\n  \"tumorType\": \"Not Applicable\"\n}\n```\n\n### Explanation:\n1. **Diagnosis**:\n   - Original: \"Von Recklinghausen's neurofibromatosis\"\n   - The standard, preferred equivalent from the controlled terminology is: \"Neurofibromatosis type 1\"\n\n2. **Assay**:\n   - Original: \"MRS\"\n   - Assuming \"MRS\" refers to \"magnetic resonance spectroscopy\" based on common terminology in scientific contexts.\n   - The standard, preferred equivalent from the controlled terminology is: \"magnetic resonance spectroscopy\"\n\n3. **Tumor Type**:\n   - Original: \"NOS\"\n   - Assuming \"NOS\" refers to \"Not Otherwise Specified,\" but since the controlled terminology does not have this term, it's best matched with \"Not Applicable.\"\n   - The standard, preferred equivalent from the controlled terminology is: \"Not Applicable\""
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2636,
              "outputTokens": 232,
              "totalTokens": 2868
            },
            "metrics": {
              "latencyMs": 3286
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2636,
          "output_tokens": 232,
          "total_tokens": 2868
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "does not apply",
          "assay": "IHC",
          "tumorType": "cNF"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation:**\n\n- \"does not apply\" is translated to \"Not Applicable\" based on the `diagnosis` enum values.\n- \"IHC\" is an acronym for \"immunohistochemistry,\" which is a valid value in the `assay` enum.\n- \"cNF\" is presumed to stand for \"Cutaneous Neurofibroma,\" a valid entry in the `tumorType` enum.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2630,
            "outputTokens": 134,
            "totalTokens": 2764
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "10af0ffb-b626-4703-afe8-fce4c1924a77",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:47:12 GMT",
                "content-type": "application/json",
                "content-length": "669",
                "connection": "keep-alive",
                "x-amzn-requestid": "10af0ffb-b626-4703-afe8-fce4c1924a77"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation:**\n\n- \"does not apply\" is translated to \"Not Applicable\" based on the `diagnosis` enum values.\n- \"IHC\" is an acronym for \"immunohistochemistry,\" which is a valid value in the `assay` enum.\n- \"cNF\" is presumed to stand for \"Cutaneous Neurofibroma,\" a valid entry in the `tumorType` enum."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2630,
              "outputTokens": 134,
              "totalTokens": 2764
            },
            "metrics": {
              "latencyMs": 2258
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2630,
          "output_tokens": 134,
          "total_tokens": 2764
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "NF-1",
          "assay": "cell survival assay",
          "tumorType": "dermal neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\nHere's the reasoning for each field:\n\n1. **Diagnosis**: \n   - The input used \"NF-1\", which is commonly shorthand for Neurofibromatosis type 1. The schema's controlled vocabulary includes \"Neurofibromatosis type 1\" exactly, so this term is used for standardization.\n\n2. **Assay**:\n   - The term \"cell survival assay\" in the input data does not match any schema enum directly. \"cell viability assay\" is the closest equivalent in the schema's allowed values, so it is used as the standardized term.\n\n3. **Tumor Type**:\n   - \"dermal neurofibroma\" is translated to \"Cutaneous Neurofibroma\" to match the schema's standardized term. Both refer to the same kind of tumor located in the skin. \n\nAll values now conform to the exact terms provided in the Target Schema.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2633,
            "outputTokens": 245,
            "totalTokens": 2878
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "f1734b20-98fd-4e1f-ac51-853519f2b6c4",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:47:15 GMT",
                "content-type": "application/json",
                "content-length": "1144",
                "connection": "keep-alive",
                "x-amzn-requestid": "f1734b20-98fd-4e1f-ac51-853519f2b6c4"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\nHere's the reasoning for each field:\n\n1. **Diagnosis**: \n   - The input used \"NF-1\", which is commonly shorthand for Neurofibromatosis type 1. The schema's controlled vocabulary includes \"Neurofibromatosis type 1\" exactly, so this term is used for standardization.\n\n2. **Assay**:\n   - The term \"cell survival assay\" in the input data does not match any schema enum directly. \"cell viability assay\" is the closest equivalent in the schema's allowed values, so it is used as the standardized term.\n\n3. **Tumor Type**:\n   - \"dermal neurofibroma\" is translated to \"Cutaneous Neurofibroma\" to match the schema's standardized term. Both refer to the same kind of tumor located in the skin. \n\nAll values now conform to the exact terms provided in the Target Schema."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2633,
              "outputTokens": 245,
              "totalTokens": 2878
            },
            "metrics": {
              "latencyMs": 3859
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2633,
          "output_tokens": 245,
          "total_tokens": 2878
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "neurofibromatosis 1",
          "assay": "ICC",
          "tumorType": "localized neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Localized Neurofibroma\"\n}\n```\n\nHere's a breakdown of the changes made:\n\n1. **diagnosis**: \n   - Original: `\"neurofibromatosis 1\"`\n   - Changed to: `\"Neurofibromatosis type 1\"` (matching the exact case and terminology from the schema)\n\n2. **assay**:\n   - Original: `\"ICC\"`\n   - Changed to: `\"immunocytochemistry\"` (using the full term from the schema since \"ICC\" is a common abbreviation)\n\n3. **tumorType**:\n   - Original: `\"localized neurofibroma\"`\n   - Changed to: `\"Localized Neurofibroma\"` (matching the exact case and terminology from the schema) \n\nThese changes ensure compliance with the specified controlled terminology in the Target Schema.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2634,
            "outputTokens": 219,
            "totalTokens": 2853
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "0282ee92-bc98-44c7-9191-d2d8b93830ed",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:47:19 GMT",
                "content-type": "application/json",
                "content-length": "1007",
                "connection": "keep-alive",
                "x-amzn-requestid": "0282ee92-bc98-44c7-9191-d2d8b93830ed"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Localized Neurofibroma\"\n}\n```\n\nHere's a breakdown of the changes made:\n\n1. **diagnosis**: \n   - Original: `\"neurofibromatosis 1\"`\n   - Changed to: `\"Neurofibromatosis type 1\"` (matching the exact case and terminology from the schema)\n\n2. **assay**:\n   - Original: `\"ICC\"`\n   - Changed to: `\"immunocytochemistry\"` (using the full term from the schema since \"ICC\" is a common abbreviation)\n\n3. **tumorType**:\n   - Original: `\"localized neurofibroma\"`\n   - Changed to: `\"Localized Neurofibroma\"` (matching the exact case and terminology from the schema) \n\nThese changes ensure compliance with the specified controlled terminology in the Target Schema."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2634,
              "outputTokens": 219,
              "totalTokens": 2853
            },
            "metrics": {
              "latencyMs": 3624
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2634,
          "output_tokens": 219,
          "total_tokens": 2853
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "Neurofibromatosis-1",
          "assay": "magnetic resonance imaging",
          "tumorType": "not determined"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis Translation**: \n   - Input: `Neurofibromatosis-1`\n   - Target Schema: `Neurofibromatosis type 1` (this is the exact match required by the schema)\n\n2. **Assay Translation**:\n   - Input: `magnetic resonance imaging`\n   - Target Schema: `conventional MRI` (this is the closest and controlled term for general MRI)\n\n3. **Tumor Type Translation**:\n   - Input: `not determined`\n   - Target Schema: `Unknown` (standardized term for undetermined types)\n\nThe translations ensure that all values strictly adhere to the specified controlled terminology in the Target Schema.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2634,
            "outputTokens": 198,
            "totalTokens": 2832
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "2a583477-affc-4440-88b5-33442484c38b",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:47:22 GMT",
                "content-type": "application/json",
                "content-length": "954",
                "connection": "keep-alive",
                "x-amzn-requestid": "2a583477-affc-4440-88b5-33442484c38b"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis Translation**: \n   - Input: `Neurofibromatosis-1`\n   - Target Schema: `Neurofibromatosis type 1` (this is the exact match required by the schema)\n\n2. **Assay Translation**:\n   - Input: `magnetic resonance imaging`\n   - Target Schema: `conventional MRI` (this is the closest and controlled term for general MRI)\n\n3. **Tumor Type Translation**:\n   - Input: `not determined`\n   - Target Schema: `Unknown` (standardized term for undetermined types)\n\nThe translations ensure that all values strictly adhere to the specified controlled terminology in the Target Schema."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2634,
              "outputTokens": 198,
              "totalTokens": 2832
            },
            "metrics": {
              "latencyMs": 2585
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2634,
          "output_tokens": 198,
          "total_tokens": 2832
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "NF2",
          "assay": "RNA sequencing",
          "tumorType": "benign neurilemmoma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation:**\n\n- **diagnosis**: \"NF2\" is translated to \"NF2-related schwannomatosis,\" which is the standard term listed in the controlled terminology.\n- **assay**: \"RNA sequencing\" is translated to \"RNA-seq,\" which is the exact term found in the controlled vocabulary for the assay.\n- **tumorType**: \"benign neurilemmoma\" is translated to \"Schwannoma,\" which is the preferred term in the schema for this type of tumor. Neurilemmoma is an older term for Schwannoma. \n\nThe JSON response adheres to the provided schema's controlled terminology.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2633,
            "outputTokens": 190,
            "totalTokens": 2823
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "2c120b79-f190-480f-9983-f5ee126b0302",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:47:24 GMT",
                "content-type": "application/json",
                "content-length": "903",
                "connection": "keep-alive",
                "x-amzn-requestid": "2c120b79-f190-480f-9983-f5ee126b0302"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation:**\n\n- **diagnosis**: \"NF2\" is translated to \"NF2-related schwannomatosis,\" which is the standard term listed in the controlled terminology.\n- **assay**: \"RNA sequencing\" is translated to \"RNA-seq,\" which is the exact term found in the controlled vocabulary for the assay.\n- **tumorType**: \"benign neurilemmoma\" is translated to \"Schwannoma,\" which is the preferred term in the schema for this type of tumor. Neurilemmoma is an older term for Schwannoma. \n\nThe JSON response adheres to the provided schema's controlled terminology."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2633,
              "outputTokens": 190,
              "totalTokens": 2823
            },
            "metrics": {
              "latencyMs": 2438
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 2633,
          "output_tokens": 190,
          "total_tokens": 2823
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "Nonmosaic NF1",
          "assay": "3D microtissue survival assay",
          "tumorType": "neurofibrosarcoma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation:**\n1. For the `diagnosis` field, \"Nonmosaic NF1\" was mapped to \"Neurofibromatosis type 1\" as it is the standard terminology for NF1 in the provided schema.\n2. For the `assay` field, \"3D microtissue survival assay\" was mapped to \"3D microtissue viability\" to match the closest available terminology.\n3. For the `tumorType` field, \"neurofibrosarcoma\" does not have a direct match but \"Neurofibroma\" is the closest standardized term available in the schema. \n\nThe corrections ensure that all values comply with the controlled terminology provided in the schema.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2639,
            "outputTokens": 194,
            "totalTokens": 2833
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "1526f198-bcf9-4486-8638-d1720ce8b2bd",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:47:27 GMT",
                "content-type": "application/json",
                "content-length": "946",
                "connection": "keep-alive",
                "x-amzn-requestid": "1526f198-bcf9-4486-8638-d1720ce8b2bd"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation:**\n1. For the `diagnosis` field, \"Nonmosaic NF1\" was mapped to \"Neurofibromatosis type 1\" as it is the standard terminology for NF1 in the provided schema.\n2. For the `assay` field, \"3D microtissue survival assay\" was mapped to \"3D microtissue viability\" to match the closest available terminology.\n3. For the `tumorType` field, \"neurofibrosarcoma\" does not have a direct match but \"Neurofibroma\" is the closest standardized term available in the schema. \n\nThe corrections ensure that all values comply with the controlled terminology provided in the schema."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2639,
              "outputTokens": 194,
              "totalTokens": 2833
            },
            "metrics": {
              "latencyMs": 2596
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2639,
          "output_tokens": 194,
          "total_tokens": 2833
        },
        "tool_calls": [],
        "tool_execution_history": []
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.8,
      "min_score": 0.3333333333333333,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 31.261778354644775,
    "token_usage": {
      "input_tokens": 26335,
      "output_tokens": 2080,
      "total_tokens": 28415
    }
  }
}